-
PurposeLight-inducible Cre recombinase (LiCre) lentiviral expression plasmid for light-induced Cre/Lox recombination
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 166663 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonePGAE0 Self-Inactivating Vector
- Backbone size w/o insert (bp) 7208
-
Vector typeLentiviral, Cre/Lox
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameLiCre
-
Alt nameAsLOV2-CreE340AD341A
-
SpeciesSynthetic; Avena sativa, Bacteriopage P4
-
Insert Size (bp)1497
-
MutationCre: E340A, D341A
- Promoter CMV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Age1 (unknown if destroyed)
- 3′ cloning site HindIII (unknown if destroyed)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byVector pGAE0 originates from Mangeot et al. Nucleic Acids Research, 2004, Vol. 32, No. 12 e102
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please note: Plasmid contains a 24bp deletion that removes one of the SV40 NLS tags. This deletion is not known to affect plasmid function.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGY577 was a gift from Gaël Yvert (Addgene plasmid # 166663 ; http://n2t.net/addgene:166663 ; RRID:Addgene_166663) -
For your References section:
A single-chain and fast-responding light-inducible Cre recombinase as a novel optogenetic switch. Duplus-Bottin H, Spichty M, Triqueneaux G, Place C, Mangeot PE, Ohlmann T, Vittoz F, Yvert G. Elife. 2021 Feb 23;10. pii: 61268. doi: 10.7554/eLife.61268. 10.7554/eLife.61268 PubMed 33620312